Expression of VEGF is controlled by hypoxia-induced expression of the transcription factor, HIF-1 (268), and it is not implausible to presume that both localised and systemic hypoxia caused by COVID-19 would lead to the overexpression or dysregulation of VEGF. This evidence concerns the gene VEGFA and COVID-19.